January 2020 Through March 2021 - COVID-19 Data Tracking & Trends 

January 2020 COVID-19 Initial Timeline of Events
  • 1/21/2020 the first case of COVID-19 in the U.S. was recorded.
  • 1/30/2020 the CDC had confirmed the first case of person to person transmission in the U.S.
  • 1/31/2020 seven cases in three states (Washington, Illinois and California) had been recorded with no deaths.
  • 1/31/2020 HHS declared Coronavirus a Public Health Emergency in the U.S.
  • 1/31/2020 the U.S. Centers for Disease Control and Prevention (CDC) issued a federal quarantine for 14 days affecting the 195 American evacuees from Wuhan, China.
  • President Trump signed an order on Jan. 31 for the U.S. to deny entry to foreign nationals who traveled to China within the preceding two weeks, aside from the immediate family of U.S. citizens.
  • 1/31/2020 Delta, American and United announced they would temporarily suspend all of their mainland China flights in response to the coronavirus outbreak.
March 2021 COVID-19 Summary As of 3/7/2021 - Twelve (13+) months after the first seven (7) cases were identified in the U.S.
  • 29.7M reported positive cases with 17.4M reported cases in November, December and January and only 2.0M in February.
  • 537.3K reported deaths with 216.2K reported deaths in November, December and January and 53.5K in February.
  • 369.2M reported tests results on about 185M people.
  • 2 vaccines were authorized in December under the FDA Emergency Use Authorization authority: Pfizer on 12/11/2020 for use in individuals 16 years of age or older; Moderna on 12/18/2020 for use in individuals 18 years of age or older.
  • A third vaccine from Johnson & Johnson, received FDA Emergency Use Authorization on February 27, 2021 and started shipping the first week in March.  The Johnson & Johnson vaccine is a single does vaccine vs the Pfizer and Moderna vaccines which are two does vaccines.
  • 116.4M doses have been distributed.
  • 90.4M total doses have been administered.
  • 58.9M  people have received 1 or more doses, 23.1% of the 18 and older population.
  • 30.7M people have received 2 doses, 12.0% of the 18 and older population

​​WHG COVID-19 Data Tracking and Trends 

The charts below represent a twelve month analysis by WHG of The United States COVID-19 Data and Trends.​
  • The Primary sources of the publicly available data is from Worldometer, an independent reference website, link listed below and the CDC. WHG tracks the data daily and calculates the trends and charts in a format to help our family, friends and clients stay informed.​​
  • Worldometer's COVID-19 data is trusted and used by dozens of news outlets including Johns Hopkins CSSE and The New York Times.
  • Source https://www.worldometers.info/coronavirus/country/us/
  • The positive cases by age and the deaths by age data are direct downloads from the CDC website as of          2-28-2021.
  • Please note that not all state and local public health agencies and/or private testing labs track or report age data  (age data represents ~76% of all reported positive cases). https://covid.cdc.gov/covid-data-tracker/#demographics ​

​ Worldometer Data and Trends as of 2-28-2021

Avg. # of New Positive Cases Per Day by Month
Positive Cases as a % of Total Tests by Month
Avg. # of New Tests Per Day by Month
Avg. COVID-19 Death Rate % vs. Recovered by Month
Avg. # of New COVID-19 Deaths Per Day by Month
Avg. # of Recovered Cases Per Day by Month

​CDC Dashboard Data as of 2-28-2021

COVID-19 Cases by Age Groups and % of Total
Data from 21,490,763 cases. Age group was available for 21,323,420 (99%) cases.
COVID-19 Deaths by Age Groups and % of Total
Data from 373,772 deaths. Age group was available for 373,738 (99%) deaths.

​Stay up to date on the latest news regarding COVID-19

  • We all want to know how to keep ourselves and our families safe and healthy. 
  • COVID-19 Resources can provide helpful information in these challenging pandemic times.
  • The following COVID-19 resources are provided so that you can access what’s important to you and your family. Testing, diagnosis, treatment and vaccinations for COVID-19 are all rapidly evolving.
Federal Government Websites
https://www.coronavirus.gov
https://www.cdc.gov
https://www.nih.gov
https://www.hhs.gov
https://www.fda.gov
https://www.cms.gov

Data and Trending Informational Websites
US Data
https://www.worldometers.info/coronavirus/country/us/

World Data
https://www.worldometers.info/coronavirus/

CDC Data Tracking and Demographics
https://covid.cdc.gov/covid-data-tracker/#demographics

​Track States’ Responses to Coronavirus – Provided by GovPredict

https://www.govpredict.com/corona-virus-resource-center
Federation of State Medical Boards
http://www.fsmb.org/
http://www.fsmb.org/opioids/

​Testing - 2021 and Beyond

As the country moves forward vaccinating 1.5M people per day, COVID-19 testing will continue to be the reality in our every-day lives. As of the mid February 2021, over 335 million test results have been reported on about 168 million people. At the same time COVID-19 testing and quarantine guidance will continue to be refined.

WHG would like to provide the information to help explain the differences between the two kinds of COVID-19 tests available today.
Per CDC Website - https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html
Two kinds of tests are available for COVID-19: : viral tests and antibody tests
A viral test tells you if you have a current infection.​
  • Authorized assays for viral testing include those that detect SARS-CoV-2 nucleic acid or antigen. Viral (nucleic acid or antigen) tests check samples from the respiratory system (such as nasal or oral swabs or saliva) to determine whether an infection with SARS-CoV-2, the virus that causes COVID-19, is present. Viral tests are recommended to diagnose acute infection of both symptomatic and asymptomatic individuals, to guide contact tracing, treatment options, and isolation requirements. Some tests are point-of-care tests, meaning results may be available at the testing site in less than an hour. Other tests must be sent to a laboratory, a process that may take at least 1-2 days.
An antibody test tells you if you had a previous infection
  • FDA has not authorized using antibody tests to diagnose SARS-CoV-2 infection, and CDC does not currently recommend using antibody testing as the sole basis for diagnosis of acute infection. In certain situations, serologic assays may be used to support clinical assessment of persons who present late in their illnesses when used in conjunction with viral detection tests.  In addition, if a person is suspected to have a post-infectious syndrome caused by SARS-CoV-2 infection (e.g., Multisystem Inflammatory Syndrome in Children; MIS-C), serologic assays may be used.

    Serologic assays for SARS-CoV-2 infection, are an important tool for surveillance and epidemiologic studies, such as understanding the transmission dynamic of the virus in the general population. Unlike direct viral detection methods, such as nucleic acid amplification or antigen detection tests that can detect acutely infected persons, antibody tests help determine whether the individual being tested was previously infected—even if that person never showed symptoms.